ASTH stock · TECH stock

ASTH vs TECH

Astrana Health Inc (ASTH) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.

Astrana Health Inc (ASTH) is a medical care facilities company listed on US.

Bio-Techne Corp (TECH) is a biotechnology company listed on US.

Latest reported ASTH revenue for 2024-12-31 was $2.03B. Net income was $49.9M. Revenue was up 46.7% from 2023-12-31 to 2024-12-31. ASTH currently screens at market cap $1.13B and trailing P/E 33.5.

Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

ASTH currently screens at market cap $1.13B and trailing P/E 33.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

Not investment advice. Open the ASTH and TECH stock pages for the full models.

Not investment advice.

Popular Stock Comparisons